INNOVATE Corp stock analysis
Want to see VATE full AI Analyst Report?
INNOVATE Corp (VATE) Stock Price & Analysis
VATE Stock Chart & Stats
- Day’s Range
- $4.25 - $4.51
- 52-Week Range
- $3.75 - $21.30
- Previous Close
- $4.57
- Volume
- N/A
- Average Volume (3M)
- 62.60K
- Market Cap
- $60.82M
- Enterprise Value
- $703.72M
- Total Cash (Recent Filing)
- $91.50M
- Total Debt (Recent Filing)
- $641.70M
- Price to Earnings (P/E)
- ―
- Beta
- 2.81
- Next Earnings
- Mar 10, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Apr 13, 2026
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue And EBITDA Growth
Strong year-over-year revenue and adjusted EBITDA growth indicates improved operating scale and demand across the portfolio. If sustained, higher earnings generation can support reinvestment, strengthen debt-servicing capacity, and improve the company’s ability to fund future strategic initiatives.
Debt Reduction And Portfolio Simplification
Selling DBMG and applying proceeds to repay debt materially simplifies the portfolio and reduces financing obligations. Lower principal balances should improve financial flexibility, reduce interest burden, and give management more capacity to allocate capital toward remaining businesses and liabilities.
Positive Cash Generation
Positive operating and free cash flow demonstrates that the business is currently converting operations into liquidity, an important support for a highly leveraged holding company. This internally generated cash can help fund obligations and reduce reliance on additional financing.
Bears Say
Negative Equity And Elevated Leverage
Negative equity reflects a weakened capital base, while substantial debt leaves the company financially exposed despite recent repayments. This structure can restrict investment capacity, increase refinancing sensitivity, and make future operating setbacks more difficult to absorb.
Thin And Inconsistent Profitability
The return to profitability is encouraging, but thin margins and a history of repeated annual losses indicate that earnings durability remains unproven. Limited profit cushion reduces resilience if operating conditions weaken and constrains the pace of internally funded growth.
Life Sciences Revenue Conversion Weakness
The sharp Life Sciences revenue decline shows that commercial demand and reported sales are not yet translating consistently. Extended conversion timelines can delay cash generation, increase execution uncertainty, and require continued investment before the platform contributes meaningfully to results.
INNOVATE Corp News
VATE FAQ
What was INNOVATE Corp’s price range in the past 12 months?
What is INNOVATE Corp’s market cap?
When is INNOVATE Corp’s upcoming earnings report date?
How were INNOVATE Corp’s earnings last quarter?
Is INNOVATE Corp overvalued?
Does INNOVATE Corp pay dividends?
What is INNOVATE Corp’s EPS estimate?
How many shares outstanding does INNOVATE Corp have?
What happened to INNOVATE Corp’s price movement after its last earnings report?
Which hedge fund is a major shareholder of INNOVATE Corp?
What is the TipRanks Smart Score and how is it calculated?
INNOVATE Corp Stock Smart Score
Company Description
INNOVATE Corp
INNOVATE Corp. (VATE), a New York-based entity founded in 1994 and previously known as HC2 Holdings, Inc. until its name change in September 2021, manages a diverse range of subsidiaries operating within the infrastructure, life sciences, and spectrum sectors across the United States. Its extensive infrastructure division delivers services such as industrial construction, structural steel work, and facility maintenance. These capabilities are applied to a wide array of projects, including commercial structures like office complexes, hotels, casinos, convention centers, sports arenas, shopping malls, and hospitals, as well as significant industrial and civic infrastructure like dams, bridges, mines, metal processing plants, refineries, pulp and paper mills, and power generation facilities. INNOVATE also manufactures specialized components such as trusses, girders, water pipes, storage tanks, tunnel liners, pressure vessels, strainers, filters, separators, and other custom products. The company additionally offers integrated solutions encompassing digital engineering, modeling, detailing, construction, heavy equipment installation, and facility services, alongside expert steel and rebar detailing and BIM modeling and management. Furthermore, it supplies equipment critical to the oil, gas, petrochemical, and pipeline industries. Within the life sciences realm, INNOVATE focuses on the development of products designed to address early osteoarthritis of the knee, as well as aesthetic and medical technologies for skin care. Finally, its spectrum operations include the management of various over-the-air broadcasting stations and the operation of Azteca America, a Spanish-language broadcast network.
- Sector
- Industrials
- Industry
- Engineering & Construction
- CEO
- Paul Kenneth Voigt
- Employees
- 3,663
- Website
- www.innovatecorp.com
- Address
- 295 Madison Avenue, New York City, NY, 10017, US
INNOVATE Corp (VATE) Earnings & Revenues
VATE Company Deck
VATE Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive, supported by 42.8% consolidated revenue growth, a return to net income, sharply higher adjusted EBITDA, strong DBMG operating results, completion of the DBMG sale, significant post-quarter debt reduction, and continued commercial and development progress at MediBeacon and R2. The company also reported lower Life Sciences revenue, weaker Spectrum results following the ownership disposition, industrial maintenance margin pressure, and higher indebtedness as of quarter end. Overall, the highlights significantly outweighed the lowlights.
View all VATE earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 0 | 0 | 12 |









